Ms. Cunicelli is executive vice president of UPMC Enterprises. She will start her new function Jan. 1, replacing Tal Heppenstall, who is retiring. She will likewise end up being an executive vice president at UPMC.
Kelly Gooch –
Wednesday, September 16th, 2020
Ms. Cunicelli is executive vice president of UPMC Enterprises. She will begin her new function Jan. 1, replacing Tal Heppenstall, who is retiring. She will also become an executive vice president at UPMC.
On Jan. 14, UPMC said it would release $1 billion to establish brand-new drugs, diagnostics and devices over the next four years..
Far, UPMC has actually invested more than $800 million in its digital health and entrepreneurial efforts through UPMC Enterprises given that creation 6 years earlier.
” Under Tals leadership, UPMC has created a effective and unique design for buying the reinvention of health care– both through our digital options that are vital to healthcare shipment and drug discovery, and through our cutting-edge translational science efforts,” Ms. Cunicelli said in a news release. “I anticipate continuing this work as head of this talented group.”.
© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by click on this link.
During her tenure, a team of more than 20 scientific and financial investment experts has formed 5 startups and invested in research study at the University of Pittsburgh, UPMC stated. The health system added that those remain in addition to financial investments with other equity capital distributes.
Ms. Cunicelli began leading UPMC Enterprises translational science efforts in 2017.
Before signing up with UPMC, Ms. Cunicelli was managing director at Bay City Capital in San Francisco. She made an MBA in finance from the University of San Francisco.
Pittsburgh-based UPMC has chosen life sciences leader Jeanne Cunicelli as president of UPMC Enterprises, its development, equity capital and commercialization arm, the health system announced Sept. 16.